About Methuselah Health
Methuselah Health is a Healthcare company based in Babraham (United Kingdom) founded in 2015, and was acquired by RxCelerate in November 2022. Novel targets for aging-related diseases are developed via proteome research. The company has 3 employees. Methuselah Health offers products and services including ProQuant. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Drug Discovery. Its legal entity is METHUSELAH HEALTH UK LIMITED.
Company details
Methuselah Health was founded in 2015 and is based in Babraham, United Kingdom. Operations are centered in the biotechnology sector, where novel targets for treating aging-linked diseases are developed. Proteome instability in such diseases is deciphered through targeted research. Technology platforms for detecting post-translational modifications across proteins in aging are being advanced. Focus remains on human disease applications within this domain.
- Headquarters Babraham, United Kingdom
- Employees 3
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website methuselah-health.com
- Social LinkedIn
- Acquired by RxCelerate (Nov 2022)
- Legal Name Methuselah Health Uk Limited
- Date of Incorporation 09 Sep, 2014
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
- Investors
- Employee Count3
- Acquired byRxCelerate
(Nov 2022)
Products & Services of Methuselah Health
Methuselah Health offers a comprehensive portfolio of products and services, including ProQuant.
Platform for quantitative analysis of proteome stability in drug research.
Investors in Methuselah Health
Methuselah Health has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include RxCelerate.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pre-clinical contract research services are offered for drug candidates. | 2012 | rxcelerate.com | Babraham, United Kingdom |
Investor details for Methuselah Health
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Methuselah Health
2 dated milestones of Methuselah Health across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Methuselah Health is founded.
- Exit Acquired by RxCelerate.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Methuselah Health (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Methuselah Health
Complete news archive for Methuselah Health
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Methuselah Health
Methuselah Health was founded in 2015.
Methuselah Health is headquartered in Babraham, United Kingdom. It is registered at Babraham, Cambridgeshire, United Kingdom.
Methuselah Health has 3 employees.
Methuselah Health was founded in 2015 and is based in Babraham, United Kingdom. Operations are centered in the biotechnology sector, where novel targets for treating aging-linked diseases are developed. Proteome instability in such diseases is deciphered through targeted research. Technology platforms for detecting post-translational modifications across proteins in aging are being advanced. Focus remains on human disease applications within this domain.
Methuselah Health offers ProQuant.
Methuselah Health has 1 investor. Key investors include RxCelerate.
Methuselah Health operates through Methuselah Health Uk Limited.
Yes. Methuselah Health was acquired by RxCelerate in November 2022.

